This guest blog about innovative financing for global health was written by Holly Wong, vice president for public policy at the International AIDS Vaccine Initiative; Dr. Mary Moran, director of health policy at The George Institute for International Health; and Dr. Paul Herrling, head of the Novartis Institutes for Developing World Medical Research. In addition to […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The following is a guest post by Jacqueline Hellen and Lisa Parker of MEASURE Evaluation While programs in low- and middle-income countries seek to support children […]